Clinical Trials Logo

Acute Biphenotypic Leukemia (ABL) clinical trials

View clinical trials related to Acute Biphenotypic Leukemia (ABL).

Filter by:
  • None
  • Page 1

NCT ID: NCT02793544 Completed - Clinical trials for Myelodysplastic Syndrome (MDS)

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Start date: December 2016
Phase: Phase 2
Study type: Interventional

This is a multi-center, single arm Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated bone marrow transplantation donors and post-transplantation cyclophosphamide (PTCy), sirolimus and mycophenolate mofetil (MMF) for graft versus host disease (GVHD) prophylaxis in patients with hematologic malignancies.